Magenta Medical, Developer of Novel Heart Failure Therapy, Secures $4 Million ... MarketWatch (press release) Ehud Schwammenthal and Mr. Yosi Tuval, Magenta Medical is developing a novel therapeutic approach to the treatment of Congestive Heart Failure (CHF). Prof. Schwammenthal, a cardiologist, and Mr. Tuval, a mechanical engineer, were also the founders ... |
